Analystreport

Galmed Pharmaceuticals Ltd (NASDAQ: GLMD) had its price target lowered by analysts at HC Wainwright from $34.00 to $29.00. They now have a "buy" rating on the stock.

Galmed Pharmaceuticals Ltd. - Ordinary Shares  (GLMD) 
Last galmed pharmaceuticals ltd. - ordinary shares earnings: 3/12 07:00 am Check Earnings Report
US:NASDAQ Investor Relations: galmedpharma.investorroom.com